Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Vertex Pharmaceuticals Inc
Recent news which mentions Vertex Pharmaceuticals Inc
Cramer's week ahead: Earnings from Disney, Palantir and Uber
May 02, 2025
Tags
Affirm Holdings Inc
Dutch Bros Inc
Investment strategy
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Abbvie Inc
Markets
Biotech and Pharmaceuticals
From
CNBC.com News
Jim Cramer says 'the market may be far healthier than we think.' Here's why
March 27, 2025
Tags
Arthur J/ Gallagher & Co/
Stock markets
Mad Money
From
CNBC.com News
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
February 21, 2025
Tags
Health care industry
Vertex Pharmaceuticals Inc
Business News
From
CNBC.com News
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
February 18, 2025
Tags
Health Insurance
Health insurance
Business
From
CNBC.com News
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
January 30, 2025
Tags
Companies
Health & Science
Vertex Pharmaceuticals Inc
From
CNBC.com News
Cramer's Lightning Round: 'I would be a seller of QuantumScape'
January 08, 2025
Tags
Markets
S&P 500
Business
From
CNBC.com News
Cramer's Lightning Round: Vertex Pharmaceuticals is a buy
October 30, 2024
Tags
Investing
Micron Technology Inc
Stock Picks
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
Biotech and Pharmaceuticals
Agios Pharmaceuticals Inc
Health & Science
From
CNBC.com News
Cramer's Lightning Round: Builders FirstSource 'can go higher'
August 28, 2024
Tags
Viking Therapeutics Inc
stocks
Investment Strategy
From
CNBC.com News
Cramer's Lighting Round: Vertex Pharmaceuticals is 'terrific'
April 08, 2024
Tags
Penumbra Inc
Mad Money
Stock markets
From
CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
Tags
Vertex Pharmaceuticals Inc
Merck & Co Inc
Health & Science
From
CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
Tags
Health & Science
Companies
Vertex Pharmaceuticals Inc
From
CNBC.com News
Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results
December 13, 2023
Tags
Biotechnology
Health care industry
Business News
From
CNBC.com News
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
December 08, 2023
Tags
Government Agencies
Business
Biotech and Pharmaceuticals
From
CNBC.com News
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023
Tags
Business News
Health & Science
US: News
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Cisco Systems Inc
Comcast Corp
CNBC Investing Club: Analysis
From
CNBC.com News
20 stocks I'm watching in the market, including Emerson, DoorDash, Royal Caribbean
October 09, 2023
Tags
Charles Schwab Corp
Royal Caribbean Cruises Ltd
Investment strategy
From
CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
Tags
CNBC Investing Club
CNBC Investing Club: Analysis
Breaking News: Markets
From
CNBC.com News
Cramer's Lightning Round: Vertex is 'excellent'
October 05, 2023
Tags
Under Armour Inc
BlackBerry
Investment strategy
From
CNBC.com News
Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more
May 01, 2023
Tags
stocks
Earnings
Everest Re Group Ltd
From
CNBC.com News
Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more
November 11, 2022
Tags
Economy
Finance
Walgreens Boots Alliance Inc
From
CNBC.com News
Cramer's lightning round: Stay with Vertex Pharmaceuticals
October 27, 2022
Tags
Mad Money
Cleveland/Cliffs Inc
Stock markets
From
CNBC.com News
Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more
October 27, 2022
Tags
stocks
Amazon/com Inc
Breaking News: Markets
From
CNBC.com News
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
July 05, 2022
Tags
Constellation Energy Corp
Netflix Inc
Stock markets
From
CNBC.com News
Cramer's lightning round: I'm sticking with Marvell Technology
June 22, 2022
Tags
Markets
Business
S&P 500
From
CNBC.com News
Stocks making the biggest moves midday: Global Payments, Moderna, Activision Blizzard and more
May 02, 2022
Tags
Global Payments Inc
Vertex Pharmaceuticals Inc
U/S/ Markets
From
CNBC.com News
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
April 04, 2022
Tags
Walgreens Boots Alliance Inc
Chevron Corp
U/S/ Markets
From
CNBC.com News
Stem cells may finally offer a cure for Type 1 diabetes
March 26, 2022
Tags
Technology
CRISPR Therapeutics AG
Novo Nordisk A/S
From
CNBC.com News
Op-ed: Investors should look at technology, health care and industrials for long-term investing potential
March 23, 2022
Tickers
WAR
Tags
Personal Finance
W W Grainger Inc
CVS Health Corp
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.